The Europe Non-invasive Prenatal Testing (NIPT) Market would witness market growth of 17.7% CAGR during the forecast period (2023-2030).
NIPT can be carried out as early as 9–10 weeks into pregnancy, giving parents and medical professionals access to vital information about the unborn child's health earlier and facilitating early interventions. NIPT is not limited to a single disorder; it can detect a wide range of chromosomal abnormalities, including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), and sex chromosome disorders. The reduced false-positive rate of NIPT results in fewer unnecessary follow-up tests and the associated anxiety for expectant parents.
The growing understanding of the technology has contributed significantly to its adoption. NIPT is now more widely available and less expensive for a wider variety of pregnant women because many insurance companies fund it. Chromosome abnormalities such as Down, Edwards, Patau, and sex chromosome diseases are primarily detected via NIPT. By analyzing cell-free DNA from the foetus in the mother's bloodstream, NIPT accurately assesses the baby's chromosomal health. NIPT can accurately determine the sex of the foetus. This information is valuable for parents who wish to know the gender of their baby and for medical reasons, such as sex-linked genetic conditions.
Prenatal care in Europe has generally been well-established and accessible, focusing on ensuring the mother's and developing foetus’s health and well-being. According to the 2022 data from the National Health Service England, the NHS in England has announced that maternity services across England will receive a funding boost of £127 million, which will assist in providing safer and more individualized care for women and their newborns. Thus, an increase in the cases of Down’s syndrome in Europe and rising prenatal care investment will boost the demand for these in the region.
The Germany market dominated the Europe Non-invasive Prenatal Testing (NIPT) Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,133.5 Million by 2030. The UK market is exhibiting a CAGR of 16.7% during (2023 - 2030). Additionally, The France market would experience a CAGR of 18.6% during (2023 - 2030).
Based on Product, the market is segmented into Consumables & Reagents, and Instruments. Based on Application, the market is segmented into Trisomy, Microdeletion Syndrome, and Others. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics. Based on Technology, the market is segmented into Next Generation Sequencing (NGS), Microarray, Polymerase Chain Reaction (PCR), and Rolling Circular Amplification. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Non-invasive Prenatal Testing (NIPT) Market will Hit USD 17.7 Billion by 2030, at a CAGR of 18.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Illumina, Inc., Natera Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Thermo Fisher Scientific, Inc., GE HealthCare Technologies, Inc., Agilent Technologies, Inc., and Pacific Biosciences of California, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Consumables & Reagents
- Instruments
By Application
- Trisomy
- Microdeletion Syndrome
- Others
By End User
- Diagnostic Laboratories
- Hospitals & Clinics
By Technology
- Next Generation Sequencing (NGS)
- Microarray
- Polymerase Chain Reaction (PCR)
- Rolling Circular Amplification
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Illumina, Inc.
- Natera Inc.
- F. Hoffmann-La Roche Ltd.
- PerkinElmer, Inc.
- Laboratory Corporation of America Holdings
- Eurofins Scientific SE
- Thermo Fisher Scientific, Inc.
- GE HealthCare Technologies, Inc.
- Agilent Technologies, Inc.
- Pacific Biosciences of California, Inc.
TABLE 1 Europe Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
TABLE 2 Europe Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
TABLE 3 Europe Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
TABLE 4 Europe Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
TABLE 5 Europe Consumables & Reagents Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Consumables & Reagents Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Instruments Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Instruments Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
TABLE 10 Europe Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
TABLE 11 Europe Trisomy Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Trisomy Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Microdeletion Syndrome Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Microdeletion Syndrome Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
TABLE 18 Europe Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
TABLE 19 Europe Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
TABLE 24 Europe Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
TABLE 25 Europe Next Generation Sequencing (NGS) Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Next Generation Sequencing (NGS) Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Microarray Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Microarray Market by Country, 2023 - 2030, USD Million
TABLE 29 Europe Polymerase Chain Reaction (PCR) Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Polymerase Chain Reaction (PCR) Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Rolling Circular Amplification Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe Rolling Circular Amplification Market by Country, 2023 - 2030, USD Million
TABLE 33 Europe Non-invasive Prenatal Testing (NIPT) Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Non-invasive Prenatal Testing (NIPT) Market by Country, 2023 - 2030, USD Million
TABLE 35 Germany Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
TABLE 36 Germany Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
TABLE 37 Germany Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
TABLE 38 Germany Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
TABLE 39 Germany Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
TABLE 40 Germany Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
TABLE 41 Germany Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
TABLE 42 Germany Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
TABLE 43 Germany Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
TABLE 44 Germany Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
TABLE 45 UK Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
TABLE 46 UK Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
TABLE 47 UK Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
TABLE 48 UK Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
TABLE 49 UK Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
TABLE 50 UK Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
TABLE 51 UK Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
TABLE 52 UK Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
TABLE 53 UK Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
TABLE 54 UK Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
TABLE 55 France Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
TABLE 56 France Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
TABLE 57 France Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
TABLE 58 France Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
TABLE 59 France Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
TABLE 60 France Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
TABLE 61 France Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
TABLE 62 France Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
TABLE 63 France Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
TABLE 64 France Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
TABLE 65 Russia Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
TABLE 66 Russia Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
TABLE 67 Russia Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
TABLE 68 Russia Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
TABLE 69 Russia Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
TABLE 70 Russia Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
TABLE 71 Russia Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
TABLE 72 Russia Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
TABLE 73 Russia Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
TABLE 74 Russia Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
TABLE 75 Spain Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
TABLE 76 Spain Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
TABLE 77 Spain Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
TABLE 78 Spain Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
TABLE 79 Spain Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
TABLE 80 Spain Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
TABLE 81 Spain Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
TABLE 82 Spain Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
TABLE 83 Spain Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
TABLE 84 Spain Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
TABLE 85 Italy Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
TABLE 86 Italy Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
TABLE 87 Italy Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
TABLE 88 Italy Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
TABLE 89 Italy Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
TABLE 90 Italy Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
TABLE 91 Italy Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
TABLE 92 Italy Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
TABLE 93 Italy Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
TABLE 94 Italy Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
TABLE 95 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
TABLE 96 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
TABLE 97 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
TABLE 98 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
TABLE 99 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
TABLE 100 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
TABLE 101 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
TABLE 102 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
TABLE 103 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
TABLE 104 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
TABLE 105 key information – Illumina, Inc.
TABLE 106 Key Information – Natera Inc.
TABLE 107 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 108 key Information – PerkinElmer, Inc.
TABLE 109 Key Information – Laboratory Corporation of America holdings
TABLE 110 Key Information – Eurofins Scientific SE
TABLE 111 Key Information – Thermo Fisher Scientific, Inc.
TABLE 112 Key Information – GE HealthCare Technologies, Inc.
TABLE 113 key Information – Agilent Technologies, Inc.
TABLE 114 Key Information – Pacific Biosciences of California, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Non-invasive Prenatal Testing (NIPT) Market
FIG 4 Porter’s Five Forces Analysis – Non-invasive Prenatal Testing (NIPT) Market
FIG 5 Europe Non-invasive Prenatal Testing (NIPT) Market share by Product, 2022
FIG 6 Europe Non-invasive Prenatal Testing (NIPT) Market share by Product, 2030
FIG 7 Europe Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2030, USD Million
FIG 8 Europe Non-invasive Prenatal Testing (NIPT) Market share by Application, 2022
FIG 9 Europe Non-invasive Prenatal Testing (NIPT) Market share by Application, 2030
FIG 10 Europe Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2030, USD Million
FIG 11 Europe Non-invasive Prenatal Testing (NIPT) Market share by End User, 2022
FIG 12 Europe Non-invasive Prenatal Testing (NIPT) Market share by End User, 2030
FIG 13 Europe Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2030, USD Million
FIG 14 Europe Non-invasive Prenatal Testing (NIPT) Market share by Technology, 2022
FIG 15 Europe Non-invasive Prenatal Testing (NIPT) Market share by Technology, 2030
FIG 16 Europe Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2030, USD Million
FIG 17 Europe Non-invasive Prenatal Testing (NIPT) Market share by Country, 2022
FIG 18 Europe Non-invasive Prenatal Testing (NIPT) Market share by Country, 2030
FIG 19 Europe Non-invasive Prenatal Testing (NIPT) Market by Country, 2019 - 2030, USD Million
FIG 20 Recent strategies and developments: Illumina, Inc.
FIG 21 Swot Analysis: Illumina, Inc.
FIG 22 Swot Analysis: Natera, Inc.
FIG 23 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 24 Swot Analysis: PerkinElmer, Inc.
FIG 25 SWOT Analysis: Laboratory Corporation of America Holdings
FIG 26 Swot Analysis: Eurofins Scientific SE
FIG 27 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 28 Recent strategies and developments: GE HealthCare Technologies, Inc.
FIG 29 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 30 Swot Analysis: Agilent Technologies, Inc.
FIG 31 Swot Analysis: Pacific Biosciences of California, Inc.